ImmunityBio Inc

9 okt 2026, 20:07 UTC

Immunitybio Inc shares advanced sharply, continuing an upward trend that began after Thursday's close, supported by broader market strength.

8 okt 2026, 23:05 UTC

Immunitybio Inc shares are trading modestly lower in after-market hours, retracing from a brief peak at Thursday's close amid a negative cumulative return.

7 okt 2026, 23:01 UTC

ImmunityBio Inc's shares declined modestly in after-market trading amid social media concerns over outdated studies related to its immunotherapy product, Anktiva.

6 okt 2026, 20:02 UTC

ImmunityBio, Inc. shares fell sharply amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate misconduct allegations against the company and its officers.

5 okt 2026, 20:07 UTC

ImmunityBio's Anktiva, combined with BCG, gains authorization for BCG-unresponsive bladder cancer, contributing to a higher share price amid positive sentiment and recent milestones.

3 okt 2026, 00:01 UTC

ImmunityBio Inc closed the week at its highest level in over five years, with anticipation building for its upcoming Q3 report and potential BCG data.

2 okt 2026, 23:05 UTC

ImmunityBio Inc reached its highest weekly close in over five years, with shares modestly higher in after-market hours despite earlier declines.

1 okt 2026, 20:07 UTC

Immunitybio Inc shares are trading lower, despite favorable social media sentiment, and remain weaker compared to Wednesday's close after early declines.

30 sep 2026, 23:30 UTC

Immunitybio Inc is trading higher during after-market hours, reflecting positive market sentiment bolstered by a revised U.S. GDP growth rate and lower PCE inflation data.

28 sep 2026, 20:07 UTC

ImmunityBio Inc is gaining attention as shares advance amid online discussions of Dr. Patrick's 19.9% stake in PDSB and positive feedback from his recent NIH and NCI presentation.

26 sep 2026, 00:01 UTC

Immunitybio Inc saw a notable increase in after-market trading, reaching its highest cumulative return since Friday's close, and is above its 20-day moving average.

25 sep 2026, 23:05 UTC

Immunitybio Inc. is trading modestly higher in after-market hours, maintaining a solid gain since Friday's close and staying above its 20-day moving average.

24 sep 2026, 23:01 UTC

Immunitybio Inc. is trading modestly higher during after-market hours, remaining above its 20-day moving average and around the midpoint of its one-month trading range.

23 sep 2026, 23:05 UTC

Immunitybio Inc. is trading modestly higher in after-market hours, remaining above its 20-day moving average and around the midpoint of its one-month trading range.

22 sep 2026, 20:02 UTC

ImmunityBio Inc. shares advanced sharply earlier but pulled back from a session high amid increased call option volume and an ongoing shareholder investigation.

17 sep 2026, 20:02 UTC

ImmunityBio Inc is trading sharply higher, nearing $12, amid notable social media attention and unusually high market volume, despite a slight pullback earlier in the session.

16 sep 2026, 20:10 UTC

Immunitybio Inc shares are declining, remaining below their 20-day moving average, following a notable early high in Wednesday's trading session.

15 sep 2026, 23:01 UTC

Immunitybio Inc shares are lower in after-market trading. Broader market sentiment may be affected by a significant decline in the New York Empire State Manufacturing Index.

14 sep 2026, 20:08 UTC

ImmunityBio Inc is gaining as it participates in key cancer conferences this week and files a patent for Anktiva to enhance immune response.

11 sep 2026, 20:03 UTC

ImmunityBio Inc is higher as it prepares for key presentations at upcoming conferences and highlights potential uses for Anktiva in cancer treatment.

10 sep 2026, 19:36 UTC

ImmunityBio shares are lower as Bronstein, Gewirtz & Grossman, LLC announces an investigation into potential corporate wrongdoing targeting prior investors.

9 sep 2026, 23:01 UTC

Immunitybio Inc. shares declined after hours, reflecting a notable drop from an earlier session high amid no specific company news identified.

8 sep 2026, 23:16 UTC

Immunitybio Inc shares are lower in after-market hours, with no specific news identified. Broader market weakness is attributed to geopolitical tensions in the Middle East.

3 sep 2026, 19:26 UTC

Immunitybio Inc's shares are higher today, reflecting positive market sentiment amid declining Treasury yields and easing labor market concerns.

2 sep 2026, 23:06 UTC

Immunitybio Inc shares are lower in after-market trading, with no specific news identified. The broader market reacted to a weaker ADP payrolls report.

31 aug 2026, 20:07 UTC

Immunitybio Inc shares are lower amid broader market pressures and rising bond yields following comments from Warsh at the Jackson Hole Economic Symposium.

29 aug 2026, 00:01 UTC

Immunitybio Inc shares are higher in after-market trading, though no specific news was identified for the price movement. The stock remains near its one-month range high.

28 aug 2026, 20:02 UTC

Immunitybio Inc. shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields. The stock remains above its 20-day moving average.

27 aug 2026, 23:01 UTC

Immunitybio Inc. traded roughly flat after-market, despite earlier gains. Broader market trends reflected mixed trading and inflation concerns ahead of a key Fed speech.

26 aug 2026, 19:16 UTC

ImmunityBio Inc. shares are trading higher as institutional interest grows, with Virginia Retirement System holding 74,500 shares and promising trial data for Anktiva.